Abstract
Gall bladder tissue specimens obtained from 112 patients were examined by high resolution magic angle spinning (HR-MAS) NMR spectroscopy. Fifty one metabolites were identified by combination of one and two-dimensional NMR spectra. To our knowledge, this is the first report on metabolic profiling of gall bladder tissues using HR-MAS NMR spectroscopy. Metabolic profiles were evaluated for differentiation between benign Chronic Cholecystitis (CC, n = 66) and xantho-granulomatous cholecystitis (XGC, n = 21) and malignant gall bladder cancer (GBC, n = 25). Increase in choline containing compounds, amino acids, taurine, nucleotides and lactate as common metabolites were observed in malignant tissues whereas lipid content was found low as compared to benign tissues. Principal component analysis obtained from the NMR data showed clear distinction between CC and GBC tissue specimens; however, 27 % of XGC tissues were classified with GBC. The partial least square discriminant analysis (PLS-DA) multivariate analysis between benign (CC, XGC) and malignant (GBC) on the training data set (CC; n = 51, XGC; n = 15, GBC; n = 19 tissues specimens) provided 100 % sensitivity and 94.12 % specificity. This PLS-DA model when executed on the spectra of unknown tissue specimens (CC; n = 15, XGC; n = 6, GBC; n = 6) classified them into the three histological categories with more than 95 % of diagnostic accuracy. Non-invasive in vivo MRS technique may be used in future to differentiate between benign (CC and XGC) and malignant (GBC) gall bladder diseases.
Similar content being viewed by others
Abbreviations
- BCA:
-
Branch chain amino acids
- CC:
-
Chronic cholecystitis
- CPMG:
-
Carr-purcell-meiboom-gill
- DQF-COSY:
-
Double quantum filtered-correlation spectroscopy
- GBC:
-
Gall bladder cancer
- HR-MAS:
-
High resolution-magic angle spinning
- PLS-DA:
-
Partial least square regression discriminant analysis
- PCA:
-
Principal component analysis
- XGC:
-
Xantho-granulomatous cholecystitis
References
Beckonert, O., Coen, M., Keun, H. C., Wang, Y., Ebbels, T. M., Holmes, E., et al. (2010). High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nature Protocols, 5(6), 1019–1032.
Beloueche-Babari, M., Peak, J. C., Jackson, L. E., Tiet, M. Y., Leach, M. O., & Eccles, S. A. (2009). Changes in choline metabolism as potential biomarkers of phospholipase C{gamma}1 inhibition in human prostate cancer cells. Molecular Cancer Therapeutics, 8(5), 1305–1311.
Benbow, E. W. (1989). Xanthogranulomatous cholecystitis associated with carcinoma of the gallbladder. Postgraduate Medical Journal, 65(766), 528–531.
Benbow, E. W. (1990). Xanthogranulomatous cholecystitis. British Journal of Surgery, 77(3), 255–256.
Benbow, E. W., & Taylor, P. M. (1988). Simultaneous xanthogranulomatous cholecystitis and primary adenocarcinoma of gallbladder. Histopathology, 12(6), 672–675.
Bharti, S. K., & Roy, R. (2012). Quantitative 1H NMR spectroscopy. Trends in Analytical Chemistry, 35, 5–26.
Bharti, S. K., Bhatia, A., Tewari, S. K., Sidhu, O. P., & Roy, R. (2011). Application of HR-MAS NMR spectroscopy for studying chemotype variations of Withania somnifera (L.) Dunal. Magnetic Resonance in Chemistry, 49(10), 659–667.
Bolan, P. J., Meisamy, S., Baker, E. H., Lin, J., Emory, T., Nelson, M., et al. (2003). In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magnetic Resonance in Medicine, 50(6), 1134–1143.
Cao, M. D., Sitter, B., Bathen, T. F., Bofin, A., Lønning, P. E., Lundgren, S., et al. (2012). Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling. NMR in Biomedicine, 25(2), 369–378.
Chan, E. C., Koh, P. K., Mal, M., Cheah, P. Y., Eu, K. W., Backshall, A., et al. (2009). Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). Journal of Proteome Research, 8(1), 352–361.
Chang, B. J., Kim, S. H., Park, H. Y., Lim, S. W., Kim, J., Lee, K. H., et al. (2010). Distinguishing xanthogranulomatous cholecystitis from the wall-thickening type of early-stage gallbladder cancer. Gut and Liver, 4(4), 518–523.
Cheng, L. L., Chang, I. W., Louis, D. N., & Gonzalez, R. G. (1998). Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Research, 58(9), 1825–1832.
Craig, A., Cloarec, O., Holmes, E., Nicholson, J. K., & Lindon, J. C. (2006). Scaling and normalization effects in NMR spectroscopic metabolomic data sets. Analytical Chemistry, 78, 2262–2267.
Dixit, V. K., Prakash, A., Gupta, A., Pandey, M., Gautam, A., Kumar, M., et al. (1998). Xanthogranulomatous cholecystitis. Digestive Diseases and Sciences, 43(5), 940–942.
Duportet, X., Aggio, R., Carneiro, S., & Villas-Bôas, S. (2011). The biological interpretation of metabolomic data can be misled by the extraction method used. Metabolomics, 8(3), 410–421.
Elwood, D. R. (2008). Cholecystitis. Surgical Clinics of North America, 88(6), 1241–1252.
Fisher, R. A., & Yates, F. (1957). Statistical tables for biological, agricultural, and medical research (5th ed.). Edinburgh: Oliver and Boyd.
Ghosh, M., Sakhuja, P., & Agarwal, A. K. (2011). Xanthogranulomatous cholecystitis: A premalignant condition? Hepatobiliary & pancreatic diseases international, 10(2), 179–184.
Glunde, K., Jacobs, M. A., & Bhujwalla, Z. M. (2006). Choline metabolism in cancer: Implications for diagnosis and therapy. Expert Review of Molecular Diagnostics, 6(6), 821–829.
Goodman, Z. D., & Ishak, K. G. (1981). Xanthogranulomatous cholecystitis. American Journal of Surgical Pathology, 5(7), 653–659.
Gribbestad, I. S., Petersen, S. B., Fjosne, H. E., Kvinnsland, S., & Krane, J. (1994). 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR in Biomedicine, 7(4), 181–194.
Griffin, J. L., & Shockcor, J. P. (2004). Metabolic profiles of cancer cells. Nature Reviews Cancer, 4(7), 551–561.
Gupta, S. K., & Shukla, V. K. (2005). Gall Bladder cancer etiopathology and treatment. Health Administrator, 17(1), 134–142.
Hollywood, K., Brison, D. R., & Goodacre, R. (2006). Metabolomics: Current technologies and future trends. Proteomics, 6(17), 4716–4723.
Houston, J. P., Collins, M. C., Cameron, I., Reed, M. W., Parsons, M. A., & Roberts, K. M. (1994). Xanthogranulomatous cholecystitis. British Journal of Surgery, 81(7), 1030–1032.
ICMR. (1996). Annual report of population based cancer registries of the National Cancer Registry Programme (1993) (p. 18). New Delhi: ICMR Publication.
Jayalakshmi, K., Sonkar, K., Behari, A., Kapoor, V. K., & Sinha, N. (2011). Lipid profiling of cancerous and benign gallbladder tissues by 1H NMR spectroscopy. NMR in Biomedicine, 24(4), 335–342.
Jessurun, J., & Albores-Saavendra, J. (1996). Gallbladder and extrahepatic biliary ducts Vol. 2 anderson’s pathology. Saint Louis: CV Mosby.
Kapoor, V. K. (2007). Advanced gallbladder cancer: Indian “middle path”. Journal of Hepato-Biliary-Pancreatic Surgery, 14(4), 366–373.
Karabulut, Z., Besim, H., Hamamci, O., Bostanoglu, S., & Korkmaz, A. (2003). Xanthogranulomatous cholecystitis. Retrospective analysis of 12 cases. Acta Chirurgica Belgica, 103(3), 297–299.
Kim, P. N., Lee, S. H., Gong, G. Y., Kim, J. G., Ha, H. K., Lee, Y. J., et al. (1999). Xanthogranulomatous cholecystitis: Radiologic findings with histologic correlation that focuses on intramural nodules. AJR. American Journal of Roentgenology, 172(4), 949–953.
Krishnani, N., Shukla, S., Jain, M., Pandey, R., & Gupta, R. K. (2000). Fine needle aspiration cytology in xanthogranulomatous cholecystitis, gallbladder adenocarcinoma and coexistent lesions. Acta Cytologica, 44(4), 508–514.
Kwon, A. H., & Sakaida, N. (2007). Simultaneous presence of xanthogranulomatous cholecystitis and gallbladder cancer. Journal of Gastroenterology, 42(8), 703–704.
Lane, M., & Gardner, D. K. (2005). Mitochondrial malate-aspartate shuttle regulates mouse embryo nutrient consumption. Journal of Biological Chemistry, 280(18), 18361–18367.
Lazcano-Ponce, E. C., Miquel, J. F., Munoz, N., Herrero, R., Ferrecio, C., Wistuba, I. I., et al. (2001). Epidemiology and molecular pathology of gallbladder cancer. CA: A Cancer Journal for Clinicians, 51(6), 349–364.
Lindon, J. C., & Nicholson, J. K. (2008). Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annual Review of Analytical Chemistry, 1(1), 45–69.
Lindon, J. C., Nicholson, J. K., Holmes, E., & Everett, J. R. (2000). Metabonomics: Metabolic processes studied by NMR spectroscopy of biofluids. Concepts in Magnetic Resonance, 12(5), 289–320.
Lindon, J. C., Holmes, E., Bollard, M. E., Stanley, E. G., & Nicholson, J. K. (2004). Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers, 9(1), 1–31.
Lopez, J. I., Elizalde, J. M., & Calvo, M. A. (1991). Xanthogranulomatous cholecystitis associated with gallbladder adenocarcinoma. A clinicopathological study of 5 cases. Tumori, 77(4), 358–360.
Makino, I., Yamaguchi, T., Sato, N., Yasui, T., & Kita, I. (2009). Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma with a false-positive result on fluorodeoxyglucose PET. World Journal of Gastroenterology, 15(29), 3691–3693.
Markley, J. L., Anderson, M. E., Cui, Q., Eghbalnia, H. R., Lewis, I. A., Hegeman, A. D., et al. (2007). New bioinformatics resources for metabolomics. Pacific Symposium on Biocomputing, 12, 157–168.
Martinez-Granados, B., Morales, J. M., Rodrigo, J. M., Del Olmo, J., Serra, M. A., Ferrandez, A., et al. (2011). Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies. International Journal of Molecular Medicine, 27(1), 111–117.
McAndrew, P. F. (1986). Fat metabolism and cancer. Surgical Clinics of North America, 66(5), 1003–1012.
McFate, T., Mohyeldin, A., Lu, H., Thakar, J., Henriques, J., Halim, N. D., et al. (2008). Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells. Journal of Biological Chemistry, 283(33), 22700–22708.
Misra, M. C., & Guleria, S. (2006). Management of cancer gallbladder found as a surprise on a resected gallbladder specimen. Journal of Surgical Oncology, 93(8), 690–698.
Misra, D., Gupta, V., Sonkar, A. A., Bajpai, U., & Roy, R. (2008). Proton HR-MAS NMR spectroscopic characterization of metabolites in various human organ tissues: Pancreas, brain and liver from trauma cases. Physiological Chemistry and Physics and Medical NMR, 40, 67–88.
Orth, K., & Beger, H. G. (2000). Gallbladder carcinoma and surgical treatment. Langenbecks Archives of Surgery, 385(8), 501–508.
Pandey, M., Vishwakarma, R. A., Gautam, A., Khatri, A. K., Roy, S. K., & Shukla, V. K. (1995). Bile, bacteria and gallbladder carcinogenesis. Journal of Surgical Oncology, 58, 282–283.
Parra, J. A., Acinas, O., Bueno, J., Guezmes, A., Fernandez, M. A., & Farinas, M. C. (2000). Xanthogranulomatous cholecystitis: Clinical, sonographic, and CT findings in 26 patients. AJR. American Journal of Roentgenology, 174(4), 979–983.
Pavlides, S., Tsirigos, A., Migneco, G., Whitaker-Menezes, D., Chiavarina, B., Flomenberg, N., et al. (2010). The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle, 9(17), 3485–3505.
Roa, I., Araya, J. C., Villaseca, M., De Aretxabala, X., Riedemann, P., Endoh, K., et al. (1996). Preneoplastic lesions and gallbladder cancer: An estimate of the period required for progression. Gastroenterology, 111(1), 232–236.
Roa, I., de Aretxabala, X., Araya, J. C., & Roa, J. (2006). Preneoplastic lesions in gallbladder cancer. Journal of Surgical Oncology, 93(8), 615–623.
Roa, I., Aretxabala, Xd, & Wistuba, I. I. (2009). Histopathology and Molecular Pathogenesis of Gallbladder Cancer. In C. R. Thomos & C. D. Fuller (Eds.), Biliary tract and gallbladder cancer: Diagnosis and therapy. New York: Demos Medical Publishing.
Roberts, K. M., & Parsons, M. A. (1987). Xanthogranulomatous cholecystitis: Clinicopathological study of 13 cases. Journal of Clinical Pathology, 40(4), 412–417.
Rocha, C. u. M, Barros, A. n. S., Gil, A. M., Goodfellow, B. J., Humpfer, E., Spraul, M., et al. (2009). Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy. Journal of Proteome Research, 9(1), 319–332.
Ros, P. R., & Goodman, Z. D. (1997). Xanthogranulomatous cholecystitis versus gallbladder carcinoma. Radiology, 203(1), 10–12.
Schirmer, B. D., Winters, K. L., & Edlich, R. F. (2005). Cholelithiasis and cholecystitis. Journal of Long-Term Effects of Medical Implants, 15(3), 329–338.
Shen, M. R., Chou, C. Y., & Ellory, J. C. (2001). Swelling-activated taurine and K+ transport in human cervical cancer cells: Association with cell cycle progression. Pflugers Archiv. European Journal of Physiology, 441(6), 787–795.
Sitter, B., Sonnewald, U., Spraul, M., Fjösne, H. E., & Gribbestad, I. S. (2002). High-resolution magic angle spinning MRS of breast cancer tissue. NMR in Biomedicine, 15(5), 327–337.
Sitter, B., Lundgren, S., Bathen, T. F., Halgunset, J., Fjosne, H. E., & Gribbestad, I. S. (2006). Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR in Biomedicine, 19(1), 30–40.
Sitter, B., Bathen, T. F., Tessem, M.-B., & Gribbestad, I. S. (2009). High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer. Progresss in Nuclear Magnetic Resonance Spectroscopy, 54(3), 239–254.
Sitter, B., Bathen, T. F., Singstad, T. E., Fjøsne, H. E., Lundgren, S., Halgunset, J., et al. (2010). Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR in Biomedicine, 23(4), 424–431.
Srivastava, S., Roy, R., Gupta, V., Tiwari, A., Srivastava, A., & Sonkar, A. (2011). Proton HR-MAS MR spectroscopy of oral squamous cell carcinoma tissues: An ex vivo study to identify malignancy induced metabolic fingerprints. Metabolomics, 7(2), 278–288.
Stenman, K., Surowiec, I., Antti, H., Riklund, K., Stattin, P., Bergh, A., et al. (2010). Detection of local prostate metabolites by HRMAS NMR spectroscopy: A comparative study of human and rat prostate tissues. Magnetic Resonance Insights, 4, 27–41.
Tazuma, S., & Kajiyama, G. (2001). Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones. Langenbecks Archives of Surgery, 386(3), 224–229.
Tessem, M.-B., Swanson, M. G., Keshari, K. R., Albers, M. J., Joun, D., Tabatabai, Z. L., et al. (2008). Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magnetic Resonance in Medicine, 60(3), 510–516.
Wang, H., Tso, V. K., Slupsky, C. M., & Fedorak, R. N. (2010). Metabolomics and detection of colorectal cancer in humans: A systematic review. Future Oncology, 6(9), 1395–1406.
Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B., et al. (2009). HMDB: A knowledgebase for the human metabolome. Nucleic Acids Res, 37(Database issue), D603–D610.
Wright, A. J., Fellows, G. A., Griffiths, J. R., Wilson, M., Bell, B. A., & Howe, F. A. (2010). Ex vivo HRMAS of adult brain tumours: Metabolite quantification and assignment of tumour biomarkers. Molecular Cancer, 9, 66–83.
Yalcin, S. (2004). Carcinoma of the gallbladder. Orphanet encyclopedia (pp. 1–5).
Yang, T., Zhang, B.-H., Zhang, J., Zhang, Y.-J., Jiang, X.-Q., & Wu, M.-C. (2007a). Surgical treatment of xanthogranulomatous cholecystitis: Experience in 33 cases. Hepatobiliary & Pancreatic Diseases International, 6(5), 504–508.
Yang, Y., Li, C., Nie, X., Feng, X., Chen, W., Yue, Y., et al. (2007b). Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis. Journal of Proteome Research, 6(7), 2605–2614.
Acknowledgments
Financial assistance from the Department of Science and Technology, Government of India is gratefully acknowledged. S. K. Bharti thanks Dr. K. Jayalakshmi Mulge and Ms Kanchan Sonkar for their help during the work.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bharti, S.K., Behari, A., Kapoor, V.K. et al. Magic angle spinning NMR spectroscopic metabolic profiling of gall bladder tissues for differentiating malignant from benign disease. Metabolomics 9, 101–118 (2013). https://doi.org/10.1007/s11306-012-0431-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11306-012-0431-7